Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | ERN1 | O75460 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.44 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | AURKA | O14965 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27090463 | 0.82 | LMNA (0.45) | LMNAERN1CYP1B1CYP1A1CYP1A2 | |
| SCHEMBL27090511 | 0.79 | LMNA (0.42) | LMNAERN1CYP1B1CYP1A1CYP1A2 | |
| SCHEMBL27090461 | 0.79 | LMNA (0.42) | LMNAERN1CYP1B1CYP1A1CYP1A2 | |
| SCHEMBL23634786 | 0.78 | LMNA (0.54) | LMNAERN1CYP1B1CYP1A1CYP1A2 | |
| SCHEMBL28667568 | 0.76 | LMNA (0.53) | LMNAERN1CYP1B1CYP1A1CYP1A2 | |
| SCHEMBL27090488 | 0.75 | SMN1; SMN2 (0.43) | LMNACYP1B1CYP1A1CYP1A2ALDH1A1 | |
| Methoxymethane SCHEMBL28676370 | 0.74 | LMNA (0.51) | LMNAERN1CYP1B1CYP1A1CYP1A2 | |
| SCHEMBL27090471 | 0.74 | LMNA (0.42) | LMNAERN1CYP1B1CYP1A1CYP1A2 | |
| SCHEMBL27090467 | 0.73 | SMN1; SMN2 (0.46) | LMNACYP1A2ALDH1A1HPGDCYP3A4 | |
| SCHEMBL18482099 | 0.73 | LMNA (0.50) | LMNAERN1CYP1B1CYP1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240051897-A1 | SYNTHESIS OF COMPLEX 15N-LABELED MOLECULES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2024-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240051897-A1 | SYNTHESIS OF COMPLEX 15N-LABELED MOLECULES | NCLN, NCL, NDUFV3 | LMNA 1483/4885ERN1 1427/4885CYP1B1 1009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.